These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18827607)

  • 1. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
    Shibaki R; Murakami S; Shinno Y; Matsumoto Y; Yoshida T; Goto Y; Kanda S; Horinouchi H; Fujiwara Y; Yamamoto N; Yamamoto N; Ohe Y
    Cancer Immunol Immunother; 2020 Jul; 69(7):1229-1236. PubMed ID: 32152703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.
    Ono A; Takahashi T; Mori K; Akamatsu H; Shukuya T; Taira T; Kenmotsu H; Naito T; Murakami H; Nakajima T; Endo M; Yamamoto N
    BMC Cancer; 2013 Jul; 13():354. PubMed ID: 23879483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.
    Tissot C; Toffart AC; Villar S; Souquet PJ; Merle P; Moro-Sibilot D; Pérol M; Zavadil J; Brambilla C; Olivier M; Couraud S
    Eur Respir J; 2015 Dec; 46(6):1773-80. PubMed ID: 26493785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
    Dunst J; Pigorsch S; Hänsgen G; Hintner I; Lautenschläger C; Becker A
    Strahlenther Onkol; 1999 Mar; 175(3):93-6. PubMed ID: 10093609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor C complements the ability of positron emission tomography to predict nodal disease in lung cancer.
    Farjah F; Madtes DK; Wood DE; Flum DR; Zadworny ME; Waworuntu R; Hwang B; Mulligan MS
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):796-803.e1-2. PubMed ID: 26320776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 update.
    Trulson I; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S111-S161. PubMed ID: 37927288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
    Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M
    Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Net platelet angiogenic activity (NPAA) correlates with progression and prognosis of non-small cell lung cancer.
    Yao L; Dong H; Luo Y; Du J; Hu W
    PLoS One; 2014; 9(4):e96206. PubMed ID: 24788022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer.
    Liu YN; Wang XB; Wang T; Zhang C; Zhang KP; Zhi XY; Zhang W; Sun KL
    Chin Med J (Engl); 2016 Sep; 129(17):2026-32. PubMed ID: 27569226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
    Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J
    Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of serum DJ-1 in lung adenocarcinoma.
    Wang L; Wei L; Miao S; Zhang W
    PeerJ; 2024; 12():e16845. PubMed ID: 38304191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
    Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
    Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.
    Muller DC; Larose TL; Hodge A; Guida F; Langhammer A; Grankvist K; Meyer K; Cai Q; Arslan AA; Zeleniuch-Jacquotte A; Albanes D; Giles GG; Sesso HD; Lee IM; Gaziano JM; Yuan JM; Hoffman Bolton J; Buring JE; Visvanathan K; Le Marchand L; Purdue MP; Caporaso NE; Midttun Ø; Ueland PM; Prentice RL; Weinstein SJ; Stevens VL; Zheng W; Blot WJ; Shu XO; Zhang X; Xiang YB; Koh WP; Hveem K; Thomson CA; Pettinger M; Engström G; Brunnström H; Milne RL; Stampfer MJ; Han J; Johansson M; Brennan P; Severi G; Johansson M
    BMJ; 2019 Jan; 364():k4981. PubMed ID: 30606716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).
    Muller DC; Hodge AM; Fanidi A; Albanes D; Mai XM; Shu XO; Weinstein SJ; Larose TL; Zhang X; Han J; Stampfer MJ; Smith-Warner SA; Ma J; Gaziano JM; Sesso HD; Stevens VL; McCullough ML; Layne TM; Prentice R; Pettinger M; Thomson CA; Zheng W; Gao YT; Rothman N; Xiang YB; Cai H; Wang R; Yuan JM; Koh WP; Butler LM; Cai Q; Blot WJ; Wu J; Ueland PM; Midttun Ø; Langhammer A; Hveem K; Johansson M; Hultdin J; Grankvist K; Arslan AA; Le Marchand L; Severi G; Johansson M; Brennan P
    Ann Oncol; 2018 Jun; 29(6):1468-1475. PubMed ID: 29617726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IL-24 combined with CA125 as screening and prognostic biomarkers for NSCLC.
    Zhang K; Qu J; Deng S; Yuan E
    Cell Biol Int; 2024 Aug; 48(8):1160-1168. PubMed ID: 38751041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.
    Colinet B; Jacot W; Bertrand D; Lacombe S; Bozonnat MC; Daurès JP; Pujol JL;
    Br J Cancer; 2005 Nov; 93(10):1098-105. PubMed ID: 16234816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.
    Laza-Briviesca R; Cruz-Bermúdez A; Nadal E; Insa A; García-Campelo MDR; Huidobro G; Dómine M; Majem M; Rodríguez-Abreu D; Martínez-Martí A; De Castro Carpeño J; Cobo M; López Vivanco G; Del Barco E; Bernabé Caro R; Viñolas N; Barneto Aranda I; Viteri S; Massuti B; Casarrubios M; Sierra-Rodero B; Tarín C; García-Grande A; Haymaker C; Wistuba II; Romero A; Franco F; Provencio M
    Clin Transl Med; 2021 Jul; 11(7):e491. PubMed ID: 34323406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study.
    Ma X; Guo W; Yang S; Zhu X; Xiang J; Li H
    Dis Markers; 2015; 2015():814670. PubMed ID: 26265795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17A as a new circulating bioindicator for non-small cell lung cancer diagnosis and prognosis.
    Wang JX; Xu XJ; Zhu ZM; Cao WL; Yang ZP; Zhen JL; Wu YY; Lu FM; Liu SW
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12004-12011. PubMed ID: 38164862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.